25248 Federal Register / Vol. 74, No. 100 / Wednesday, May 27, 2009 / Notices 

Time: 8:30 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Doubletree Hotel, 8120 Wisconsin 

Ave., Bethesda, MD 20814. 

Contact Person: Joyce C. Pegues, BS, BA, 

PhD, Scientific Review Officer, Special 

Review and Logistics Branch, Division of 

Extramural Activities, National Cancer 

Institute, NIH, 6116 Executive Boulevard, 

Room 7149, Bethesda, MD 20892–8329, 301– 

594–1286, peguesj@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel, Physical 

Sciences—Oncology Center. 

Date: June 29–30, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda Marriott North Conference 

Center, 5701 Marinelli Road, Rockville, MD 

20852. 

Contact Person: Kenneth L. Bielat, BS, 

PhD, Scientific Review Officer, Special 

Review Logistics Branch, Division of 

Extramural Activities, National Cancer 

Institute, NIH, 6116 Executive Boulevard, 

Room 7147, Bethesda, MD 20892–8329, 

301496–7576, bielatk@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel, 

Comprehensive Minority Institution/Cancer 

Center Partnership. 

Date: July 16–17, 2009. 

Time: 8:30 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Legacy Hotel, 1775 Rockville 

Pike, Rockville, MD 20852. 

Contact Person: Joyce C. Pegues, BS, BA, 

PhD, Scientific Review Officer, Special 

Review and Logistics Branch, Division of 

Extramural Activities, National Cancer 

Institute, NIH, 6116 Executive Boulevard, 

Room 7149, Bethesda, MD 20892–8329, 301– 

594–1286, peguesj@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel, Biospecimen Prep. 

Date: July 21, 2009. 

Time: 8 a.m. to 11a.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hilton Alexandria at Old Town, 

1767 King Street, Alexandria, VA 22314. 

Contact Person: Marvin L. Salin, PhD, 

Scientific Review Officer, Special Review 

and Logistics Branch, Division of Extramural 

Activities, National Cancer Institute, NIH, 

6116 Executive Boulevard, Room 7073, 

Bethesda, MD 20892–8329, 301–496–0694, 

msalin@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: May 15, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–12206 Filed 5–26–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Office of the Director, National 

Institutes of Health; Notice of Meeting 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of a meeting of the 

Recombinant DNA Advisory Committee. 

The meeting will be open to the 

public, with attendance limited to space 

available. Individuals who plan to 

attend and need special assistance, such 

as sign language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

Name of Committee: Recombinant DNA 

Advisory Committee. 

Date: June 16–17, 2009. 

Time: June 16, 2009, 2 p.m. to 5:30 p.m. 

Agenda: The Recombinant DNA Advisory 

Committee will review and discuss selected 

human gene transfer protocols as well as a 

discussion of Biosafety Considerations for the 

Cloning of the Risk Group 4 

Mononegavirales: Marburg, Nipah and 

Hendra viruses—in Non-Pathogenic E. coli. 

Please check the meeting agenda at http:// 

oba.od.nih.gov/rdna.html for more 

information. 

Place: National Institutes of Health, 

Building 31, 31 Center Drive, Floor 6C, Room 

6, Bethesda, MD 20892. 

Time: June 17, 2009, 8:15 a.m. to 3 p.m. 

Agenda: The Recombinant DNA Advisory 

Committee will review and discuss selected 

human gene transfer protocols as well as 

related data management activities. Please 

check the meeting agenda at http:// 

oba.od.nih.gov/rdna.html for more 

information. 

Place: National Institutes of Health, 

Building 31, 31 Center Drive, Floor 6C, Room 

6, Bethesda, MD 20892. 

Contact Person: Laurie Lewallen, Advisory 

Committee Coordinator, Office of 

Biotechnology Activities, National Institutes 

of Health, 6705 Rockledge Drive, Room 750, 

Bethesda, MD 20892–7985. 301–496–9838. 

lewallla@od.nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

onto the NIH campus. All visitor vehicles, 

including taxicabs, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors will be asked to show one 

form of identification (for example, a 

government-issued photo ID, driver’s license, 

or passport) and to state the purpose of their 

visit. 

Information is also available on the 

Institute’s/Center’s home page: http:// 

www4.od.nih.gov/oba/, where an agenda and 

any additional information for the meeting 

will be posted when available. 

OMB’s ‘‘Mandatory Information 

Requirements for Federal Assistance Program 

Announcements’’ (45 FR 39592, June 11, 

1980) requires a statement concerning the 

official government programs contained in 

the Catalog of Federal Domestic Assistance. 

Normally NIH lists in its announcements the 

number and title of affected individual 

programs for the guidance of the public. 

Because the guidance in this notice covers 

virtually every NIH and Federal research 

program in which DNA recombinant 

molecule techniques could be used, it has 

been determined not to be cost effective or 

in the public interest to attempt to list these 

programs. Such a list would likely require 

several additional pages. In addition, NIH 

could not be certain that every Federal 

program would be included as many Federal 

agencies, as well as private organizations, 

both national and international, have elected 

to follow the NIH Guidelines. In lieu of the 

individual program listing, NIH invites 

readers to direct questions to the information 

address above about whether individual 

programs listed in the Catalog of Federal 

Domestic Assistance are affected. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.14, Intramural Research 

Training Award; 93.22, Clinical Research 

Loan Repayment Program for Individuals 

from Disadvantaged Backgrounds; 93.232, 

Loan Repayment Program for Research 

Generally; 93.39, Academic Research 

Enhancement Award; 93.936, NIH Acquired 

Immunodeficiency Syndrome Research Loan 

Repayment Program; 93.187, Undergraduate 

Scholarship Program for Individuals from 

Disadvantaged Backgrounds, National 

Institutes of Health, HHS) 

Dated: May 15, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–12208 Filed 5–26–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of General Medical 

Sciences; Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 


erowe on PROD1PC63 with NOTICES